AnnaMButturiniMD
Pediatric Hematology & Oncology • Los Angeles, CAAssociate Professor, Pediatrics, USC School of Medicine
Dr. Butturini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 323-669-5928Fax+1 323-660-7128
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 1996 - 1997
Univ Parma- Fac MedClass of 1980
Certifications & Licensure
CA State Medical License 1996 - 2026- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma Start of enrollment: 2002 Dec 01
Publications & Presentations
PubMed
- 10 citationsAuthor Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers.David M. Hyman, Sarina Anne Piha-Paul, Helen Won, Jordi Rodon, Cristina Saura
Nature. 2019-02-28 - 545 citationsHER kinase inhibition in patients with HER2- and HER3-mutant cancers.David M. Hyman, Sarina Anne Piha-Paul, Helen Won, Jordi Rodon, Cristina Saura
Nature. 2018-02-08 - 12 citationsA randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemiaEtan Orgel, Nicole M. Mueske, Richard Sposto, Vicente Gilsanz, Tishya A. L. Wren
Leukemia & Lymphoma. 2017-02-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
